GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » EPS without NRI

Adcock Ingram Holdings (JSE:AIP) EPS without NRI : R548.72 (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings EPS without NRI?

Adcock Ingram Holdings's earnings per share without non-recurring items for the six months ended in Dec. 2023 was R2.86. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was R548.72.

During the past 12 months, Adcock Ingram Holdings's average earnings per share (NRI) Growth Rate was 10177.60% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 408.40% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 105.90% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 30.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Adcock Ingram Holdings's EPS without NRI or its related term are showing as below:

JSE:AIP' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -24.6   Med: 2   Max: 408.4
Current: 408.4

During the past 13 years, Adcock Ingram Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 408.40% per year. The lowest was -24.60% per year. And the median was 2.00% per year.

JSE:AIP's 3-Year EPS without NRI Growth Rate is ranked better than
99.76% of 846 companies
in the Drug Manufacturers industry
Industry Median: 9.2 vs JSE:AIP: 408.40

Adcock Ingram Holdings's EPS (Diluted) for the six months ended in Dec. 2023 was R2.84. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was R5.49.

Adcock Ingram Holdings's EPS (Basic) for the six months ended in Dec. 2023 was R2.91. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was R5.63.


Adcock Ingram Holdings EPS without NRI Historical Data

The historical data trend for Adcock Ingram Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings EPS without NRI Chart

Adcock Ingram Holdings Annual Data
Trend Sep13 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.22 4.18 4.05 4.93 548.70

Adcock Ingram Holdings Semi-Annual Data
Mar14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.42 2.51 2.83 545.87 2.86

Competitive Comparison of Adcock Ingram Holdings's EPS without NRI

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's PE Ratio without NRI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's PE Ratio without NRI falls into.



Adcock Ingram Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was R548.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings  (JSE:AIP) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Adcock Ingram Holdings EPS without NRI Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings (JSE:AIP) Business Description

Traded in Other Exchanges
N/A
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.